These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9111571)

  • 1. Severe insulin resistance treated with insulin lispro.
    Gill G; Williams G
    Lancet; 1997 Jan; 349(9046):211. PubMed ID: 9111571
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in severe insulin resistance with frequent injections of lispro insulin.
    Raine CH; Krzyston MJ; Amr M; Hydrick L
    J Natl Med Assoc; 1999 Jul; 91(7):410-3. PubMed ID: 10643214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient with subcutaneous-insulin resistance treated by insulin lispro plus heparin.
    Tokuyama Y; Nozaki O; Kanatsuka A
    Diabetes Res Clin Pract; 2001 Dec; 54(3):209-12. PubMed ID: 11689276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report.
    Lahtela JT; Knip M; Paul R; Antonen J; Salmi J
    Diabetes Care; 1997 Jan; 20(1):71-3. PubMed ID: 9028697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
    Rave K; Heinemann L; Puhl L; Gudat U; Woodworth JR; Weyer C; Heise T
    Diabetes Care; 1999 May; 22(5):865-6. PubMed ID: 10332707
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes.
    Hedman CA; Lindström T; Arnqvist HJ
    Diabetes Care; 2001 Jun; 24(6):1120-1. PubMed ID: 11375381
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical aspects of Insulin Lispro (LY275585)].
    Kuzuya T
    Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
    [No Abstract]   [Full Text] [Related]  

  • 8. Lispro insulin-induced lipoatrophy: a new case.
    Al-Khenaizan S; Al Thubaiti M; Al Alwan I
    Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A breath of life for inhaled insulin: severe subcutaneous insulin resistance as an indication?
    Mastrandrea LD
    Pediatr Diabetes; 2010 Sep; 11(6):377-9. PubMed ID: 20738801
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact on clinical status and quality of life of switching from regular insulin to insulin lispro among patients using insulin pumps.
    Campbell RK; Sclar DA; Robison LM; Stowers JK; Ferguson JC; Trippe BS; Kayne DM
    Diabetes Educ; 1998; 24(1):95-9. PubMed ID: 9526330
    [No Abstract]   [Full Text] [Related]  

  • 11. [Taking the peak out of blood pressure. Diabetics can also live spontaneously].
    MMW Fortschr Med; 1999 Dec; 141(49-50):66-7. PubMed ID: 10726151
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lispro insulin is suitable for external pumps but not for implantable pumps.
    Demirdjian S; Bardin C; Savin S; Zirinis P; Chast F; Slama G; Sélam JL
    Diabetes Care; 1998 May; 21(5):867-8. PubMed ID: 9589258
    [No Abstract]   [Full Text] [Related]  

  • 14. [Remission of diabetes mellitus].
    Suzuki E; Kashiwagi A
    Nihon Rinsho; 1997 Nov; 55 Suppl():597-603. PubMed ID: 9434534
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
    Griffin ME; Feder A; Tamborlane WV
    Diabetes Care; 2001 Jan; 24(1):174. PubMed ID: 11194227
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of lipoatrophy with Lispro insulin without insulin pump therapy.
    Arranz A; Andia V; López-Guzmán A
    Diabetes Care; 2004 Feb; 27(2):625-6. PubMed ID: 14747261
    [No Abstract]   [Full Text] [Related]  

  • 17. Limitations to subcutaneous insulin administration in type 1 diabetes.
    Chen JW; Christiansen JS; Lauritzen T
    Diabetes Obes Metab; 2003 Jul; 5(4):223-33. PubMed ID: 12795655
    [No Abstract]   [Full Text] [Related]  

  • 18. NICE recommends insulin pumps for young people only if injections impractical.
    Dinsdale P
    BMJ; 2008 Jul; 337():a1067. PubMed ID: 18664508
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe insulin resistance treated with insulin lispro.
    Henrichs HR; Unger H; Trautmann ME; Pfützner A
    Lancet; 1996 Nov; 348(9036):1248. PubMed ID: 8898065
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin lispro: a useful advance in insulin therapy.
    Heller S
    Expert Opin Pharmacother; 2003 Aug; 4(8):1407-16. PubMed ID: 12877647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.